Shots:
Health Canada has approved Portela for alleviating osteoarthritis pain in cats. The company plans to launch Portela commercially in Canada and the EU in 2026
In a nine-month European trial, Portela eased OA pain and was well tolerated, including in cats with IRIS stage 1–3 kidney disease. Approved in the EU
Portela is a…
Shots:
The US FDA has granted Emergency Use Authorization (EUA) to Credelio CAT (lotilaner) for the treatment of New World screwworm (NWS; Cochliomyia hominivorax) infestations in cats
EUA was based on the research assessing Credelio CAT to treat Old World screwworm in cats & research on the efficacy of Credelio against New World screwworm in dogs…
Shots:
Dechra has launched Solovecin (cefovecin sodium) for the treatment of skin infections in dogs & cats across the US
Solovecin treats skin infections in dogs (secondary superficial pyoderma, abscesses, & wounds) caused by S. intermedius & S. canis, & in cats (wounds & abscesses) caused by susceptible strains of P. multocida
Solovecin, a long-acting…
Shots:
The CVMP has recommended Portela (relfovetmab) for alleviating osteoarthritis pain in cats, with an EC decision expected in Q4’25 & commercial launch planned for 2026
Opinion was based on superior safety & efficacy in cats across trials, incl. cats with IRIS stage 1–3 kidney disease, & showed relieved osteoarthritis pain
Portela is a long-acting…
Shots:
PBI-Gordon Companies has reported US availability of Felycin-CA1 (sirolimus delayed-release tablets) via licensed veterinarians
Felycin-CA1 has been conditionally approved by the US FDA for managing ventricular hypertrophy in cats with subclinical hypertrophic cardiomyopathy (HCM) based on RAPACATÂ study
The company is seeking a full new animal drug approval of Felycin-CA1 for cats with HCM through the…
Shots:
PBI-Gordon Companies has acquired TriviumVet, incl. its product Felycin-CA1 (Sirolimus Delayed-Release Tablets), adding it to the PRN Pharmacal portfolio (PBI-Gordon’s Brand) to expand its animal healthcare product portfolio
Felycin-CA1 will be available for veterinary orders by Aug 2025, with PRN Pharmacal expanding its team by hiring over 50 additional employees
Felycin-CA1 has been conditionally…
Shots:
Spirited Paw (Standard Process' Brand) has launched Calm supplement to manage stress-related behaviors like occasional anxiety in cats & dogs
Calm consists of scientifically-backed ingredients along with plant-based nutrients like Kalette, ginger & chamomile extracts, grown on Standard Process’ 868-acre USDA-certified organic farm Â
Calm contains L-Theanine, L-Tryptophan, & marine-derived Magnesium, with L-Theanine tested in…
Shots:
GumPaws has launched gummy supplements to support dental health in dogs
GumPaws gummies are designed with specific density & chewiness to improve friction, helping clean plaque & support dental care in dogs, offering dual-benefit compared to conventional supplements
Gummies are formulated with scientifically-backed natural ingredients that start absorbing through the gums &…
Shots:
Pet Honesty launched Urinary Tract Health, a supplement to promote cats' urinary health, expanding its feline wellness product portfolio
Urinary Tract Health chews contain cranberry, glucosamine, & probiotics to support normal urinary function, gut health & maintain urine pH
This is a dual-texture cat supplement to increase palatability in cats, plus provide…

